Skip to main content
Erschienen in: Abdominal Radiology 2/2010

01.04.2010 | Invited Feature Section

Pancreatic adenocarcinoma versus chronic pancreatitis: differentiation with triple-phase helical CT

verfasst von: Yasunari Yamada, Hiromu Mori, Shunro Matsumoto, Hiro Kiyosue, Yuko Hori, Norio Hongo

Erschienen in: Abdominal Radiology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Chronic pancreatitis and pancreatic adenocarcinoma often show similar clinical and imaging appearances. This study aims to differentiate chronic pancreatitis from pancreatic adenocarcinoma by defining enhancement patterns in both pathologic conditions during triple-phase helical CT.

Methods

The study included 42 patients with chronic pancreatitis and 85 patients with pancreatic adenocarcinoma. CT images obtained according to protocol A (scan delays, 30, 60, and 150 s; 300 mg I/mL contrast material) or protocol B (scan delays, 40, 70, and 150 s; 370 mg I/mL contrast material) were retrospectively evaluated.

Results

Mean contrast enhancement value of normal pancreas peaked in the first phase (early-washout pattern) while that of chronic pancreatitis peaked in the second phase (delayed-washout pattern), and that of pancreatic adenocarcinoma gradually rose (increasing pattern) in both protocols. Diagnostic indices for pancreatic adenocarcinoma were 82.4% and 94.1% for sensitivity, 83% and 83% for specificity, 82.7% and 90.4% for accuracy in protocols A and B, respectively, when differentiation between chronic pancreatitis and pancreatic adenocarcinoma was performed based on time-attenuation curve patterns.

Conclusion

Our results indicate that time attenuation curves obtained from triple-phase helical CT in protocol B provide useful information in differentiating chronic pancreatitis from pancreatic adenocarcinoma.
Literatur
1.
Zurück zum Zitat Chijiwa K, Saiki S, et al. (1996) “Mass-forming” pancreatitis masquerades as pancreatic carcinoma. Int J Pancreatol 20:27–35 Chijiwa K, Saiki S, et al. (1996) “Mass-forming” pancreatitis masquerades as pancreatic carcinoma. Int J Pancreatol 20:27–35
2.
3.
Zurück zum Zitat Bramhall SR, Allum WH, Jones AG, et al. (1995) Treatment and survival in 13, 560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 82:111–115CrossRefPubMed Bramhall SR, Allum WH, Jones AG, et al. (1995) Treatment and survival in 13, 560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 82:111–115CrossRefPubMed
4.
Zurück zum Zitat Smith CD, Behrns KE, van Heerden JA, et al. (1994) Radical pancreatoduodenectomy for misdiagnosed pancreatic mass. Br J Surg 81:585–589CrossRefPubMed Smith CD, Behrns KE, van Heerden JA, et al. (1994) Radical pancreatoduodenectomy for misdiagnosed pancreatic mass. Br J Surg 81:585–589CrossRefPubMed
5.
Zurück zum Zitat Tajima Y, Kuroki T, Tsutsumi R, Kim T, et al. (2007) Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol 13:858–865PubMed Tajima Y, Kuroki T, Tsutsumi R, Kim T, et al. (2007) Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol 13:858–865PubMed
6.
Zurück zum Zitat Kim JK, Altun E, Elias J, et al. (2007) Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI. J Magn Reson Imaging 26:313–322CrossRefPubMed Kim JK, Altun E, Elias J, et al. (2007) Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI. J Magn Reson Imaging 26:313–322CrossRefPubMed
7.
Zurück zum Zitat Ichikawa T, Sou H, Araki T, et al. (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221:107–116CrossRefPubMed Ichikawa T, Sou H, Araki T, et al. (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221:107–116CrossRefPubMed
8.
Zurück zum Zitat Lu DSK, Vedantham S, Krasney RM, et al. (1996) Two-phase helical CT for pancreatic tumors: pancreatic and hepatic phase enhancement of tumor, pancreas and vascular structures. Radiology 199:697–701PubMed Lu DSK, Vedantham S, Krasney RM, et al. (1996) Two-phase helical CT for pancreatic tumors: pancreatic and hepatic phase enhancement of tumor, pancreas and vascular structures. Radiology 199:697–701PubMed
9.
Zurück zum Zitat Fletcher JG, Wiersema MJ, Farrel MA, et al. (2003) Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 229:81–90CrossRefPubMed Fletcher JG, Wiersema MJ, Farrel MA, et al. (2003) Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 229:81–90CrossRefPubMed
10.
Zurück zum Zitat Zeman RK, Silverman PM, Ascher SM, et al. (1995) Helical (spiral) CT of the pancreas and biliary tract. Radiol Clin North Am 33:887–902PubMed Zeman RK, Silverman PM, Ascher SM, et al. (1995) Helical (spiral) CT of the pancreas and biliary tract. Radiol Clin North Am 33:887–902PubMed
11.
Zurück zum Zitat Tublin ME, Tessler FN, Cheng AL, et al. (1999) Effect of injection rate of contrast medium on pancreatic and hepatic helical CT. Radiology 210:97–101PubMed Tublin ME, Tessler FN, Cheng AL, et al. (1999) Effect of injection rate of contrast medium on pancreatic and hepatic helical CT. Radiology 210:97–101PubMed
12.
Zurück zum Zitat Schlieman MG, Ho HS, Bold RJ (2003) Utility of tumor markers in determining resectability of pancreatic cancer. Arch Surg 138:951–955CrossRefPubMed Schlieman MG, Ho HS, Bold RJ (2003) Utility of tumor markers in determining resectability of pancreatic cancer. Arch Surg 138:951–955CrossRefPubMed
13.
Zurück zum Zitat Yoshida K, Toki F, Takeuchi T, et al. (1995) Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568CrossRefPubMed Yoshida K, Toki F, Takeuchi T, et al. (1995) Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568CrossRefPubMed
14.
Zurück zum Zitat Okazaki K, Uchida K, Ohara M, et al. (2000) Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 118:573–581CrossRefPubMed Okazaki K, Uchida K, Ohara M, et al. (2000) Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 118:573–581CrossRefPubMed
15.
Zurück zum Zitat Yang DH, Kim KW, Kim TK, et al. (2006) Autoimmune pancreatitis: radiologic findings in 20 patients. Abdom Imaging 31:94–102CrossRefPubMed Yang DH, Kim KW, Kim TK, et al. (2006) Autoimmune pancreatitis: radiologic findings in 20 patients. Abdom Imaging 31:94–102CrossRefPubMed
16.
Zurück zum Zitat Bluemke DA, Cameron JL, Hruban RH, et al. (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197:381–385PubMed Bluemke DA, Cameron JL, Hruban RH, et al. (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197:381–385PubMed
17.
Zurück zum Zitat Diehl S, Lehmann K, Sadick M, et al. (1998) Pancreatic cancer: value of dual-phase helical CT in assessing respectability. Radiology 206:373–378PubMed Diehl S, Lehmann K, Sadick M, et al. (1998) Pancreatic cancer: value of dual-phase helical CT in assessing respectability. Radiology 206:373–378PubMed
18.
Zurück zum Zitat Tabuchi T, Itoh K, Ohshio G, et al. (1999) Tumor staging of pancreatic adenocarcinoma using early and late-phase helical CT. AJR Am J Roentgenol 173:375–380PubMed Tabuchi T, Itoh K, Ohshio G, et al. (1999) Tumor staging of pancreatic adenocarcinoma using early and late-phase helical CT. AJR Am J Roentgenol 173:375–380PubMed
19.
Zurück zum Zitat Vargas R, Nino-Murcia M, Trueblood W, et al. (2004) MDCT in pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol 182:419–425PubMed Vargas R, Nino-Murcia M, Trueblood W, et al. (2004) MDCT in pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol 182:419–425PubMed
20.
Zurück zum Zitat Kim T, Murakami T, Takamura M, et al. (2001) Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol 177:367–371PubMed Kim T, Murakami T, Takamura M, et al. (2001) Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol 177:367–371PubMed
21.
Zurück zum Zitat Furukawa H, Takayasu K, Mukai K, et al. (1996) Late contrast-enhanced CT for small pancreatic carcinoma: delayed enhanced area on CT with histopathological correlation. Hepatogastroenterology 43:1230–1237PubMed Furukawa H, Takayasu K, Mukai K, et al. (1996) Late contrast-enhanced CT for small pancreatic carcinoma: delayed enhanced area on CT with histopathological correlation. Hepatogastroenterology 43:1230–1237PubMed
22.
Zurück zum Zitat Demachi H, Matsui O, Kobayashi S, et al. (1997) Histological influence on contrast-enhanced CT of pancreatic ductal adenocarcinoma. J Comput Assist Tomogr 21:980–985CrossRefPubMed Demachi H, Matsui O, Kobayashi S, et al. (1997) Histological influence on contrast-enhanced CT of pancreatic ductal adenocarcinoma. J Comput Assist Tomogr 21:980–985CrossRefPubMed
23.
Zurück zum Zitat Kim T, Murakami T, Takahashi S, et al. (1998) Effect of injection rates of contrast material on arterial phase hepatic CT. AJR Am J Roentgenol 171:429–432PubMed Kim T, Murakami T, Takahashi S, et al. (1998) Effect of injection rates of contrast material on arterial phase hepatic CT. AJR Am J Roentgenol 171:429–432PubMed
24.
Zurück zum Zitat Awai K, Hori S (2003) Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT. Eur Radiol 13:2155–2160CrossRefPubMed Awai K, Hori S (2003) Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT. Eur Radiol 13:2155–2160CrossRefPubMed
25.
Zurück zum Zitat Itoh S, Satake H, Ohta T, et al. (2002) Pancreatic ductal adenocarcinoma showing iso-attenuation in early-phase contrast-enhanced CT: comparison with histopathological findings. Radiat Med 20:59–67PubMed Itoh S, Satake H, Ohta T, et al. (2002) Pancreatic ductal adenocarcinoma showing iso-attenuation in early-phase contrast-enhanced CT: comparison with histopathological findings. Radiat Med 20:59–67PubMed
26.
Zurück zum Zitat Boland GW, O’Malley ME, Saez M, et al. (1999) Pancreatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma. AJR Am J Roentgenol 172:605–608PubMed Boland GW, O’Malley ME, Saez M, et al. (1999) Pancreatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma. AJR Am J Roentgenol 172:605–608PubMed
27.
Zurück zum Zitat McNulty NJ, Francis IR, Platt JF, et al. (2001) Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 220:97–102PubMed McNulty NJ, Francis IR, Platt JF, et al. (2001) Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 220:97–102PubMed
28.
Zurück zum Zitat Tajima Y, Matsuzaki S, Furui J, et al. (2004) Use of the time-signal intensity curve from dynamic magnetic resonance imaging to evaluate remnant pancreatic fibrosis after pancreaticojejunostomy in patients undergoing pancreaticoduodenectomy. Br J Surg 91:595–600CrossRefPubMed Tajima Y, Matsuzaki S, Furui J, et al. (2004) Use of the time-signal intensity curve from dynamic magnetic resonance imaging to evaluate remnant pancreatic fibrosis after pancreaticojejunostomy in patients undergoing pancreaticoduodenectomy. Br J Surg 91:595–600CrossRefPubMed
29.
Zurück zum Zitat Cubilla AL, Fitzgerald PJ (1984) Tumors of the exocrine pancreas. In: Atlas of tumor pathology. 2nd ed, vol 19, Washington, DC: Armed Forces Institute of Pathology, pp 1–40 Cubilla AL, Fitzgerald PJ (1984) Tumors of the exocrine pancreas. In: Atlas of tumor pathology. 2nd ed, vol 19, Washington, DC: Armed Forces Institute of Pathology, pp 1–40
30.
Zurück zum Zitat Kuniyasu H, Abburuzzese JL, Cleary KR, et al. (2001) Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma. Int J Oncol 19:681–685PubMed Kuniyasu H, Abburuzzese JL, Cleary KR, et al. (2001) Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma. Int J Oncol 19:681–685PubMed
31.
Zurück zum Zitat De Angelis C, Valente G, Spaccapietra M, et al. (1992) Histological study of alcoholic, nonalcoholic, and obstructive chronic pancreatitis. Pancreas 7:193–196PubMedCrossRef De Angelis C, Valente G, Spaccapietra M, et al. (1992) Histological study of alcoholic, nonalcoholic, and obstructive chronic pancreatitis. Pancreas 7:193–196PubMedCrossRef
32.
Zurück zum Zitat Schilling MK, Redaelli C, Reber PU, et al. (1999) Microcirculation in chronic pancreatitis: a laser Doppler flow study. Pancreas 19:21–25CrossRefPubMed Schilling MK, Redaelli C, Reber PU, et al. (1999) Microcirculation in chronic pancreatitis: a laser Doppler flow study. Pancreas 19:21–25CrossRefPubMed
33.
Zurück zum Zitat Lewis MP, Lo SK, Reber PU, et al. (2000) Endoscopic measurement of pancreatic tissue perfusion in patients with chronic pancreatitis and control patients. Gastrointest Endosc 51:195–199CrossRefPubMed Lewis MP, Lo SK, Reber PU, et al. (2000) Endoscopic measurement of pancreatic tissue perfusion in patients with chronic pancreatitis and control patients. Gastrointest Endosc 51:195–199CrossRefPubMed
34.
Zurück zum Zitat Tsuda T, Mochizuki T, Kikuchi K, et al. (2001) Late-phase enhancement of the upstream portion of pancreatic adenocarcinoma on dual-phase helical CT. Abdom Imaging 26:635–639CrossRefPubMed Tsuda T, Mochizuki T, Kikuchi K, et al. (2001) Late-phase enhancement of the upstream portion of pancreatic adenocarcinoma on dual-phase helical CT. Abdom Imaging 26:635–639CrossRefPubMed
Metadaten
Titel
Pancreatic adenocarcinoma versus chronic pancreatitis: differentiation with triple-phase helical CT
verfasst von
Yasunari Yamada
Hiromu Mori
Shunro Matsumoto
Hiro Kiyosue
Yuko Hori
Norio Hongo
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
Abdominal Radiology / Ausgabe 2/2010
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-009-9579-7

Weitere Artikel der Ausgabe 2/2010

Abdominal Radiology 2/2010 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.